Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.
gadolinium
hypertrophic cardiomyopathy
machine learning
myocardial fibrosis
radiomics
Journal
European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788
Informations de publication
Date de publication:
22 03 2022
22 03 2022
Historique:
received:
07
12
2020
pubmed:
30
3
2021
medline:
9
4
2022
entrez:
29
3
2021
Statut:
ppublish
Résumé
Cardiovascular magnetic resonance (CMR) with late-gadolinium enhancement (LGE) is increasingly being used in hypertrophic cardiomyopathy (HCM) for diagnosis, risk stratification, and monitoring. However, recent data demonstrating brain gadolinium deposits have raised safety concerns. We developed and validated a machine-learning (ML) method that incorporates features extracted from cine to identify HCM patients without fibrosis in whom gadolinium can be avoided. An XGBoost ML model was developed using regional wall thickness and thickening, and radiomic features of myocardial signal intensity, texture, size, and shape from cine. A CMR dataset containing 1099 HCM patients collected using 1.5T CMR scanners from different vendors and centres was used for model development (n=882) and validation (n=217). Among the 2613 radiomic features, we identified 7 features that provided best discrimination between +LGE and -LGE using 10-fold stratified cross-validation in the development cohort. Subsequently, an XGBoost model was developed using these radiomic features, regional wall thickness and thickening. In the independent validation cohort, the ML model yielded an area under the curve of 0.83 (95% CI: 0.77-0.89), sensitivity of 91%, specificity of 62%, F1-score of 77%, true negatives rate (TNR) of 34%, and negative predictive value (NPV) of 89%. Optimization for sensitivity provided sensitivity of 96%, F2-score of 83%, TNR of 19% and NPV of 91%; false negatives halved from 4% to 2%. An ML model incorporating novel radiomic markers of myocardium from cine can rule-out myocardial fibrosis in one-third of HCM patients referred for CMR reducing unnecessary gadolinium administration.
Identifiants
pubmed: 33779725
pii: 6199608
doi: 10.1093/ehjci/jeab056
pmc: PMC9125682
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
532-542Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL127015
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL154744
Pays : United States
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
Références
JACC Cardiovasc Imaging. 2016 Dec;9(12):1392-1402
pubmed: 27450876
Am Heart J. 2011 Jun;161(6):1073-7
pubmed: 21641353
Front Cardiovasc Med. 2020 Jan 24;7:1
pubmed: 32039241
Radiol Cardiothorac Imaging. 2020 Jun 25;2(3):e190216
pubmed: 32734275
Radiology. 2018 Jan;286(1):103-112
pubmed: 28836886
Invest Radiol. 2017 Jun;52(6):317-323
pubmed: 28368880
Eur J Radiol. 2018 May;102:61-67
pubmed: 29685546
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Mol Aspects Med. 2019 Feb;65:70-99
pubmed: 30056242
JACC Heart Fail. 2018 May;6(5):364-375
pubmed: 29655825
J Cardiovasc Magn Reson. 2017 Nov 30;19(1):95
pubmed: 29191206
Invest Radiol. 2019 Apr;54(4):221-228
pubmed: 30433891
J Magn Reson Imaging. 2020 Sep;52(3):906-919
pubmed: 31971296
Sci Rep. 2018 May 9;8(1):7391
pubmed: 29743511
Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):816-823
pubmed: 29029139
J Am Heart Assoc. 2020 Oct 20;9(19):e016797
pubmed: 33006296
Int J Pediatr. 2016;2016:1980636
pubmed: 27974896
Comput Methods Programs Biomed. 2017 May;143:97-111
pubmed: 28391823
J Med Invest. 2019;66(1.2):35-37
pubmed: 31064950
Magn Reson Med. 2019 May;81(5):3192-3201
pubmed: 30565296
Circ Cardiovasc Imaging. 2020 Jun;13(6):e009894
pubmed: 32507020
J Am Coll Cardiol. 2003 May 7;41(9):1561-7
pubmed: 12742298
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
J Magn Reson Imaging. 2021 Sep;54(3):787-794
pubmed: 33650227
Front Cardiovasc Med. 2020 Nov 02;7:591368
pubmed: 33240940
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
Circ Cardiovasc Imaging. 2017 Aug;10(8):
pubmed: 28798137
Eur Radiol. 2013 Feb;23(2):307-18
pubmed: 22865271
JACC Cardiovasc Imaging. 2018 Jan;11(1):48-59
pubmed: 28624408
Radiology. 1991 Sep;180(3):671-5
pubmed: 1871277
Heart Fail Rev. 2018 Sep;23(5):723-731
pubmed: 29968223
Int J Cardiol. 2013 Jun 20;166(2):413-20
pubmed: 22130224
J Magn Reson Imaging. 2018 Apr;47(4):891-912
pubmed: 29131444
Eur Heart J Cardiovasc Imaging. 2020 Apr 1;21(4):349-356
pubmed: 32142107
J Am Coll Cardiol. 2004 Jun 16;43(12):2260-4
pubmed: 15193690
EBioMedicine. 2020 Apr;54:102726
pubmed: 32268274
Congest Heart Fail. 2008 Jul-Aug;14(4 Suppl 1):5-8
pubmed: 18772638
Front Cardiovasc Med. 2020 Dec 02;7:586236
pubmed: 33344517
Adv Chronic Kidney Dis. 2017 May;24(3):138-146
pubmed: 28501075
Expert Rev Precis Med Drug Dev. 2019;4(2):59-72
pubmed: 31080889
N Engl J Med. 2010 Aug 5;363(6):552-63
pubmed: 20818890
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
JACC Cardiovasc Imaging. 2019 Oct;12(10):1946-1954
pubmed: 30660549
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929